Furthermore, our findings indicated that the small molecule STM2457 targeting METTL3-METTL14 complex exerted similar inhibitory effects on MDS cells, both in vitro and in vivo, as it does on AML cells [19]. This evidence concerns the gene METTL3 and acute myeloid leukemia.